Plasma platelet-activating factor acetylhydrolase deficiency in Japanese patients with asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 3, 1999, Pages 974-979

  Satoh, Nagato ^a   Asano, Koichiro ^a   Naoki, Katsuhiko ^a   Fukunaga, Kouichi ^a   Iwata, Makiko ^a   Kanazawa, Minoru ^a   Yamaguchi, Kazuhiro ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE;

ADOLESCENT; ADULT; AGED; ALLELISM; ALLERGIC ASTHMA; ARTICLE; ASTHMA; ATOPY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; ENZYME DEFICIENCY; FEMALE; GENE FREQUENCY; GENE MUTATION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0032987419     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.3.9807093     Document Type: Article

References (29)

1. 1. Benveniste, J., P. M. Henson, and C. G. Cochrane. 1972. Leukocyte-dependent histamine release from rabbit platelets: the role of IgE, basophils, and a platelet-activating factor. J. Exp. Med. 136:1356-1377.
2. 2. Barnes, P. J. 1991. Platelet activating factor and asthma. Ann. N.Y. Acad. Sci. 629:193-204.
3. 3. Ishii, S., T. Nagase, F. Tashiro, K. Ikuta, S. Sato, I. Waga, K. Kume, J. Miyazaki, and T. Shimizu. 1997. Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. EMBO J. 16:133-142.
4. 4. Averill, F., W. Hubbard, and M. Liu. 1991. Detection of platelet activating factor (PAF) and lyso-PAF in bronchoalveolar lavage fluids from allergic subjects following antigen challenge (abstract). Am. Rev. Respir. Dis. 143:A811.
5. 5. Crea, A. E., J. A. Nakhosteen, and T. H. Lee. 1992. Mediator concentrations in bronchoalveolar lavage fluid of patients with mild asymptomatic bronchial asthma. Eur. Respir. J. 5:190-195.
6. 6. Horii, T., H. Okazaki, M. Kino, Y. Kobayashi, K. Satouchi, and K. Saito. 1991. Platelet-activating factor detected in bronchoalveolar lavage fluids from an asthmatic patient. Lipids 26:1292-1296.
7. 7. Stenton, S. C., E. N. Court, W. P. Kingston, P. Goadby, C. A. Kelly, M. Duddridge, C. Ward, D. J. Hendrick, and E. H. Walters. 1990. Platelet-activating factor in bronchoalveolar lavage fluid from asthmatic subjects. Eur. Respir. J. 3:408-413.
8. 8. Shin, M. H., F. J. Averill, W. C. Hubbard, F. H. Chilton, F. M. Baroody, M. C. Liu, and R. M. Naclerio. 1994. Nasal allergen challenge generates 1-o-hexadecyl-2-lyso-sn-glycero-3-phosphocholine. Am. J. Respir. Crit. Care Med. 149:660-666.
9. 9. Stafforini, D. M., S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre. 1996. Mammalian platelet-activating factor acetylhydrolase. Biochim. Biophys. Acta 1301:161-173.
10. 10. Tjoelker, L. W., C. Wilder, C. Eberhardt, D. M. Stafforini, G. Dietsch, B. Schimpf, S. Hooper, H. Le Trong, L. S. Cousens, G. A. Zimmerman, Y. Yamada, T. M. McIntyre, S. M. Prescott, and P. W. Gray. 1995. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature 374:549-553.
11. 11. Satoh, K., T. Imaizumi, Y. Kawamura, H. Yoshida, S. Takamatsu, S. Mizono, B. Shoji, and M. Takamatsu. 1988. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease. Prostaglandins 35:685-698.
12. 12. Imaizumi, T., K. Satoh, H. Yoshida, Y. Kawamura, M. Hiramoto, M. Koyanagi, S. Takamatsu, and M. Takamatsu. 1990. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers. Heart Vessels 5:81-86.
13. 13. Tetta, C., F. Bussolino, V. Modena, G. Montrucchio, G. Segoloni, G. Pescarmona, and G. Camussi. 1990. Release of platelet-activating factor in systemic lupus crythematosus. Int. Arch. Allergy Appl. Immunol. 91:244-256.
14. 14. Miyaura, S., N. Maki, W. Byrd, and J. M. Johnston. 1991. The hormonal regulation of platelet-activating factor acetylhydrolase activity in plasma. Lipids 26:1015-1020.
15. 15. Dulioust, A., P. Hilliquin, C. J. Menkes, J. Benveniste, and B. Arnoux. 1992. Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases. Scand. J. Rheumatol. 21:161-164.
16. 16. Graham, R. M., C. J. Stephens, W. Silvester, L. L. Leong, M. J. Sturm, and R. R. Taylor. 1994. Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis. Crit. Care Med. 22:204-212.
17. 17. Goudevenos, J., A. D. Tselepis, D. Tsoukatos, G. Grekas, J. Kritikakos, and D. Sideris. 1995. Platelet aggregability to platelet activating factor at rest and after exercise in patients with coronary artery disease. Eur. Heart J. 16:1036-1043.
18. 18. Miwa, M., T. Miyake, T. Yamanaka, J. Sugatani, Y. Suzuki, S. Sakata, Y. Araki, and M. Matsumoto. 1988. Characterization of serum platelet-activating factor (PAF) acetylhydrolase: correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J. Clin. Invest. 82:1983-1991.
19. 19. Stafforini, D. M., K. Satoh, D. L. Atkinson, L. W. Tjoelker, C. Eberhardt, H. Yoshida, T. Imaizumi, S. Takamatsu, G. A. Zimmerman, T. M. McIntyre, P. W. Gray, and S. M. Prescott. 1996. Platelet-activating factor acetylhydrolase deficiency: a missense mutation near the active site of an anti-inflammatory phospholipase. J. Clin. Invest. 97: 2784-2791.
20. 20. National Institutes of Health. 1997. Guidelines for the Diagnosis and Management of Asthma. NIH Publication No. 97-4051.
21. 21. Stafforini, D. M., S. M. Prescott, and T. M. McIntyre. 1987. Human plasma platelet-activating factor acetylhydrolase: purification and properties. J. Biol Chem. 262:4223-4230.
22. 22. Stafforini, D. M., T. M. McIntyre, M. E. Carter, and S. M. Prescott. 1987. Human plasma platelet-activating factor acetylhydrolase: association with lipoprotein particles and role in the degradation of platelet-activating factor. J. Biol. Chem. 262:4215-4222.
23. 23. Yamada, Y., and M. Yokota. 1997. Loss of activity of plasma platelet-activating factor acetylhydrolase due to a novel Gln281→Arg mutation. Biochem. Biophys. Res. Commun. 236:772-775.
24. 24. Tsukioka, K., M. Matsuzaki, M. Nakamata, H. Kayahara, and T. Nakagawa. 1996. Increased plasma level of platelet-activating factor (PAF) and decreased serum PAF acetylhydrolase (PAFAH) activity in adults with bronchial asthma. J. Investig. Allergol. Clin. Immunol. 6: 22-29.
25. 25. Hiramoto, M., H. Yoshida, T. Imaizumi, N. Yoshizumi, and K. Satoh. 1997. A mutation in plasma platelet-activating factor acethylhydrolase (Val279→Phe) is a genetic risk factor for stroke. Stroke 28:2417-2420.
26. 26. Triggiani, M., V. De Marino, M. Sofia, S. Faraone, G. Ambrosio, L. Carratu, and G. Marone. 1997. Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage. Am. J. Respir. Crit. Care Med. 156:94-100.
27. 27. Hozawa, S., Y. Haruta, S. Ishioka, and M. Yamakido. 1995. Effects of a PAF antagonist, Y-24180, on bronchial hyperresponsiveness in patients with asthma. Am. J. Respir. Crit. Care Med. 152:1198-1202.
28. 28. Kagoshima, M., N. Tomomatsu, Y. Iwahisa, S. Yamaguchi, M. Matsuura, Y. Kawakami, and M. Terasawa. 1997. Suppressive effects of Y-24180, a receptor antagonist to platelet activating factor (PAF), on antigen-induced asthmatic responses in guinea pigs. Inflamm. Res. 46:147-153.
29. 29. Yoshida, H., K. Satoh, M. Koyama, M. Hiramoto, and S. Takamatsu. 1996. Deficiency of plasma platelet-activating factor acetylhydrolase: roles of blood cells. Am. J. Hematol. 53:158-164.